诱性寡氧核酸向STAT3和STAT5进行癌症治疗的进展
Maryam Mahjoubin-Tehran1, Samaneh Rezaei2, Ali H Eid3
1Department of Biotechnology, Mashhad University of Medical Sciences, Mashhad, Iran.
Biochemical pharmacology
|June 6, 2025
概括
诱惑性寡氧核酸 (ODN) 通过向信号转换器和转录激活器 (STAT) 蛋白质,对癌症治疗具有前景. 本综述探讨了诱ODN对抗癌症疗法的STAT的影响.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 信号转换器和转录激活器 (STAT) 蛋白质是参与癌细胞增殖的关键细胞质转录因子.
- 在癌症中,STAT3和STAT5特别重要,这使得它们成为治疗干预的主要目标.
- 目前的小分子抑制剂面临局限性,需要探索替代治疗策略.
研究的目的:
- 在癌症治疗中审查以STAT蛋白为向的诱寡氧核酸 (ODN) 的治疗潜力.
- 提供关于诱ODN的研究及其对瘤学STAT的影响的简要评估.
- 突出诱ODN相对于传统的小分子和模仿药的优势.
主要方法:
- 对调查鱼ODN针对STAT蛋白质的研究的文献综述.
- 在临床前癌症模型中分析诱ODN的特异性和有效性的研究.
- 评估诱ODN将STAT转录因子禁用的机制.
主要成果:
- 诱ODN在结合和禁用目标STAT蛋白质方面表现出高的特异性.
- 基于寡核酸的疗法,包括诱ODN,为癌症治疗提供了一个有希望的替代方案.
- 与诱惑相比,诱惑ODN提供了一种独特的方法来调节转录因子活性.
结论:
- 诱惑性ODN代表了针对癌症治疗中STAT的可行和有效策略.
- 为了克服癌症治疗当前的局限性,需要进一步研究和开发诱ODN.
- 诱惑性ODN的特异性和作用机制凸显了它们在向癌症治疗中的潜力.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K


